Monopar Therapeutics Stock Jumps 4X, Inks Licensing Pact With AstraZeneca For Once Terminated Phase 3 Candidate For Rare Genetic Disorder
Monopar secures an exclusive license from AstraZeneca's Alexion for ALXN-1840, aiming to advance treatment for Wilson's ...
Prime Medicine to Highlight New Preclinical Data, Including In Vivo Data in Wilson’s Disease, at Upcoming Scientific Meetings
On-track to initiate IND-enabling activities for Wilson’s Disease program in 4Q 2024, with IND or CTA filing expected in 1H 2026 --CAMBRIDGE, ...
Medscape5d
Wilson's Disease: An Update
and can occur early or late in the disease course. Rarely, patients exhibit chorea of generalized or localized distribution over one half of the body. [31] Myoclonic or tonic-clonic seizure ...
The Tab12d
Rare illness and Durham: Two contrasting Freshers’ Week’s and how I recovered
Whilst all of that is also true for me, Durham symbolises something far greater – the end point on my road to recovery from a ...
StarsInsider on MSN1mon
What exactly is Wilson's disease?
Unless you have Wilson's disease, or you know someone who does, you've probably never heard of this rare genetic condition. With non-specific symptoms that mainly affect the brain and the liver, this ...
Medscape2d
613 Cases of Splenic Rupture Without Risk Factors or Previously Diagnosed Disease
Gaucher's disease, Wilson's disease, pheochromocytoma, afibrinogenemia and ruptured ectopic pregnancy. Conclusions Emergency physicians should be attuned to the fact that rupture of the spleen ...
Jim Wilson's Gemma Biotherapeutics gets up to $100M in funding
Gemma Biotherapeutics, one of two companies launched by former University of Pennsylvania gene therapy program director Dr.
Eagle-Tribune10d
Prime Medicine to Highlight New Preclinical Data, Including In Vivo Data in Wilson’s Disease,
On-track to initiate IND-enabling activities for Wilson’s Disease program in 4Q 2024, with IND or CTA filing expected in 1H 2026 -- CAMBRIDGE, Mass., Oct. 15, 2024 (GLOBE NEWSWIRE ...